Eyebrow text

This is a title

There is room for additional content. This shouldn’t be longer that a couple of sentences. Make sure to check the amount of characters.

Hero 2
Hero 2
Moleculen image for Science
Text + Image
Blok met keuze foto links of rechts + accent kleuren (cluster colors) + USP’s

We aim to complement
Science Clusters across Europe

A valuable network of locally connected science clusters enhances proximity to various resources. Our Global Connectivity adds an extra dimension to our specialised assets in local clusters by providing opportunities to connect with others from our global network.

Connectivity leverages the full power of our network of science clusters to support growth for our clients.

  • Present in 6 countries
  • In 4 innovative sectors
  • At 27 leading campuses
  • With 69 assets
  • And 400+ clients

 

We aim to complement
Science Clusters across Europe

A valuable network of locally connected science clusters enhances proximity to various resources. Our Global Connectivity adds an extra dimension to our specialised assets in local clusters by providing opportunities to connect with others from our global network.

Connectivity leverages the full power of our network of science clusters to support growth for our clients.

  • Present in 6 countries
  • In 4 innovative sectors
  • At 27 leading campuses
  • With 69 assets
  • And 400+ clients

 

Text 2
Een blok met twee kolommen

Pioneering advancements in life sciences & health for global impact.

Kadans Science Partner focuses on bringing people together to overcome global challenges.

Life sciences and health (LSH) are essential to shaping our environment and lifestyles, tackling global challenges like climate change and the profound effects of (bio)genetics on humanity. Today, countless opportunities exist for us to better understand our bodies and the world around us. The question is: why not connect and explore these possibilities?

The dynamic LSH sector is driving groundbreaking research – from using Artificial Intelligence (AI) to target cancer cells, to mapping out diseases such as dementia and autoimmune disorders. It encompasses innovations in biogenetics, genetics, and even explores alternative energy sources and new materials.

Accordeon 1
Een blok met een image en een accordeon

At Kadans, we aim to bring people together to overcome global challenges.

INTROTEXT: Our core values are connect, collaborate and innovate. Our core values are connect, collaborate and innovate. Our core values are connect, collaborate and innovate.

Connect

We believe in connecting people with shared goals and ambitions. We actively organise oppurtunities for them to meet and foster our community to enable meaningful conversations and lasting relationships. In collaboration with our partners, the Kadans community supports and strengthens the innovation ecosystem.

Collaborate

We believe in connecting people with shared goals and ambitions. We actively organise oppurtunities for them to meet and foster our community to enable meaningful conversations and lasting relationships. In collaboration with our partners, the Kadans community supports and strengthens the innovation ecosystem.

Support

Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.

By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.

Local proximity

Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.

By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.

Our science clusters

Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.

By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.

Science and technology

Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.

By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.

Enhancing your chances

Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.

By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.

Close to resources

Being close to resources, scientists, and companies in life sciences and health is crucial for research success. Our science clusters provide close proximity, making it easier to connect with like-minded professionals and access fresh ideas. This proximity ensures you can find the talent, capital, and expertise you need.

By being situated in these vibrant hubs, you benefit from immediate access to a network of researchers and organisations, enhancing your chances of achieving your goals.

Text 1
Een blok met een titel en een text

Kadans Science Partner

Expanding opportunities in Europe’s top science and technology clusters

Discover the advantages of each location and find the perfect environment for your business.

Text + image 2
Blok met foto links + tekst rechts met effect circles

Kadans Science Partner

Over 20+ years of experience
in modern lab- & workspaces

At Kadans, we bring innovators together to tackle global challenges. By investing in and developing specialised spaces across Europe’s leading science clusters, we provide more than just workspaces—we offer access to the talent, resources, and networks needed to drive success.

Whether in Life Sciences & Health, Food, Energy, or the Digital Economy, we connect you with the right people and organisations to help you grow, innovate, and change the world.

All around Europe
Met 18 toonaangevende clusters in Nederland, bieden we hoogwaardige werk- en onderzoeksruimtes binnen dynamische ecosystemen.
500+
Met 18 toonaangevende clusters in Nederland, bieden we hoogwaardige werk- en onderzoeksruimtes binnen dynamische ecosystemen.
10 Locaties
Met 18 toonaangevende clusters in Nederland, bieden we hoogwaardige werk- en onderzoeksruimtes binnen dynamische ecosystemen.
Text 3 + tabs
Blok met tabs links + content rechts. Keuze uit een primary achtergrond of wit.

Leading innovations in life sciences and health

Advanced Molecular and Cellular Mechanisms

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

Data and Artificial Intelligence

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Drug Discovery, Development and Manufacturing

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

Regenerative Medicine and (Stem) Cell Therapy

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

Leading innovations in life sciences and health

Advanced Molecular and Cellular Mechanisms

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

Data and Artificial Intelligence

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Drug Discovery, Development and Manufacturing

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

Regenerative Medicine and (Stem) Cell Therapy

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

At Kadans, the Advanced Molecular and Cellular Mechanisms cluster stands out with the groundbreaking work of Prof. dr. Sonja Zweegman. Her innovative approach to developing treatments for multiple myeloma could revolutionise the field. Prof. Zweegman’s team has pioneered the CCR-CAR T cell, a novel technique that enhances CAR T cells with an additional ‘antenna’ to improve tumour cell binding and elimination.

Explore more about how our Advanced Molecular & Cellular Mechanisms cluster is driving innovation and learn about other collaborative clusters in The Netherlands and UK.

Text + testimonials
Een blok met text links en testimonials rechts

Prof. dr. Sonja Zweegman’s cutting-edge research on multiple myeloma treatment.

The Advanced Molecular and Cellular Mechanisms cluster is proud to have Prof. dr. Sonja Zweegman as one of its key figures. Known for her groundbreaking work in the treatment of multiple myeloma, Prof. Zweegman is revolutionising the field with a novel approach that aims to develop therapies independently from the pharmaceutical industry—and potentially in record time.

“Revolutionising cancer treatment goes beyond individual breakthroughs; it’s about fostering global collaboration. By connecting experts from across disciplines and countries, we can accelerate the development of therapies that bring real hope and transform the future for patients worldwide.”
Prof. dr. Sonja Zweegman
Hematology, Multiple Myeloma
“Collaboration is key. In the intersection of data and bioinformatics, the right partnerships can accelerate breakthroughs in healthcare research.”
Prof. Peter van der Spek
Clinical Bioinformatics
“The future of medical breakthroughs lies in collaboration. Every patient case we study offers a unique puzzle, and by connecting with researchers across disciplines, we can find new ways to predict, treat, and understand disease.”
Dr. Louise Jones
Breast Pathology
“Revolutionising cancer treatment goes beyond individual breakthroughs; it’s about fostering global collaboration. By connecting experts from across disciplines and countries, we can accelerate the development of therapies that bring real hope and transform the future for patients worldwide.”
Prof. dr. Sonja Zweegman
Hematology, Multiple Myeloma
“Collaboration is key. In the intersection of data and bioinformatics, the right partnerships can accelerate breakthroughs in healthcare research.”
Prof. Peter van der Spek
Clinical Bioinformatics
“The future of medical breakthroughs lies in collaboration. Every patient case we study offers a unique puzzle, and by connecting with researchers across disciplines, we can find new ways to predict, treat, and understand disease.”
Dr. Louise Jones
Breast Pathology
Topics
Een blok met topics

Key topics

Hier is ruimte voor een stukje tekst.

#AI
#‘Incurable’ diseases
#Next-Generation Energy & Materials
#Precision medicine
#(Bio)genetics
Video
Een blok met ruimte voor een video

Subtitle

Expanding opportunities in Europe’s top science and technology clusters

Discover the advantages of each location and find the perfect environment for your business to thrive.

Logo’s
Een blok met ruimte voor Logo’s. Meerdere varianten mogelijk: Met of zonder slider

Sluit je aan bij deze vooruitstrevende bedrijven

Sluit je aan bij deze vooruitstrevende bedrijven

 

Logo's van partners
Logo's van partners
Logo's van partners
Logo's van partners
Logo's van partners
Logo's van partners
Logo's van partners
Full width image
Image full width with a parralax effect
CTA banner 1
CTA banner with text align centre

Ruimte voor een subtitle

We staan klaar om je te helpen en al je vragen te beantwoorden

There is room for additional content. This shouldn’t be longer that a couple of sentences. Make sure to check the amount of characters.

CTA banner 2

Science clusters offer access to collaboration opportunities. Interested in joining?

Bel, mail of chat met Rik

Science clusters offer access to collaboration opportunities. Interested in joining?

Bel, mail of chat met Rik

Science clusters offer access to collaboration opportunities. Interested in joining?

Bel, mail of chat met Rik

Science clusters offer access to collaboration opportunities. Interested in joining?

Bel, mail of chat met Rik

Science clusters offer access to collaboration opportunities. Interested in joining?

Bel, mail of chat met Rik

Team members
Blok met team members

Country leads Development and Asset managment

The key to a successful science cluster is the presence of economic, physical and network drivers.

Chiel van Dijen is the International Head of Development of Kadans Science Partner
Chiel van Dijen International Head of Development
Edward Joslin is the Head of Development for Kadans Science Partner in the UK and Ireland
Edward Joslin Country Lead Development United Kingdom
Elsa Ferrard is the Head of the French department of Kadans Science Partner
Elsa Ferrard Country Lead France France
James Sheppard is the International Head of Asset Management of Kadans Science Partner
James Sheppard International Head of Commercial Strategy

Country leads Development and Asset managment

The key to a successful science cluster is the presence of economic, physical and network drivers.

Rob van Overbeek is Commercial Development Manager for Kadans Science Partner for the Netherlands for West NL
Rob van Overbeek Commercial Development Manager – West NL The Netherlands
Jasper Schipper is Commercial Manager for Kadans Science Partner in the Netherlands for Groningen
Jasper Schipper Commercial Manager – Groningen The Netherlands
Teun Lebbink is Commercial Manager for Kadans Science Partner in the Netherlands for the Randstad area of Rotterdam and Dordrecht
Teun Lebbink Commercial Manager – Breda & Randstad The Netherlands
Demi van Erp is Commercial Manager for Kadans Science Partner in the Netherlands for Breda and Eindhoven
Demi van Erp Commercial Manager – Breda & Eindhoven The Netherlands
Jens van den Bongard is Commercial Manager for Kadans Science Partner in the Netherlands for Wageningen and Nijmegen
Jens van den Bongard Commercial Manager – Nijmegen & Wageningen The Netherlands
Kurt de Nil is Commercial Asset Manager for Kadans Science Partner in Belgium
Kurt de Nil Commercial Asset Manager Belgium
Varvara Poymetyeva is Commercial Manager for Kadans Science Partner GmbH in Germany
Varvara Poymetyeva Commercial Manager Germany
Antonio Díaz Garcia is Asset Manager for Kadans Science Partner in Spain
Antonio Díaz García Asset Manager Spain

Klaar om samen te innoveren?

Hier is ruimte voor text.

Rob van Overbeek is Commercial Development Manager for Kadans Science Partner for the Netherlands for West NL
Rob van Overbeek Commercial Development Manager – West NL

Klaar om samen te innoveren?

Hier is ruimte voor text.

Rob van Overbeek is Commercial Development Manager for Kadans Science Partner for the Netherlands for West NL
Rob van Overbeek Commercial Development Manager – West NL

Klaar om samen te innoveren?

Hier is ruimte voor text.

Rob van Overbeek is Commercial Development Manager for Kadans Science Partner for the Netherlands for West NL
Rob van Overbeek Commercial Development Manager – West NL

Klaar om samen te innoveren?

Hier is ruimte voor text.

Rob van Overbeek is Commercial Development Manager for Kadans Science Partner for the Netherlands for West NL
Rob van Overbeek Commercial Development Manager – West NL

Klaar om samen te innoveren?

Hier is ruimte voor text.

Rob van Overbeek is Commercial Development Manager for Kadans Science Partner for the Netherlands for West NL
Rob van Overbeek Commercial Development Manager – West NL
Featured items